400 CHEMOTHERAPY JAN Table 1 Cases of drop outs

Similar documents
CHEMOTHERAPY JAN Fig. 1 Structure of cephradine

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.

Fig. 1 Chemical structure of TE-031 Code number: TE-031 Chemical name: (-) (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-dideoxy-3-C-methyl-3-

VOL. 34 S-2 CHEMOTH8RAPY 913

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human

CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX

VOL.42 S-1 methicillin-susceptible Staphylococcus aureus (MSSA), Staphylococcus epidermidis, Enterococcus faecalis, Escherichia coli, Klebsiella pneum


CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote

Fig. 1 Chemical structure of DL-8280

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )

Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent

CHEMOTHERAPY MAY. 1988

Hisao Takayasu Department of Urology, Faculty of Medicine, University of Tokyo Masaaki Ohkoshi Department of Urology, Tokai University School of Medic


CHEMOTHERAPY APR Fig. 2 The inactivation of aminoglycoside antibiotics by PC-904 Fig. 3 Serum concentration of PC-904 (1) Fig. 4 Urinary recover

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

CHEMOTHERAPY DEC (NFLX), ofloxacin (OFLX), ciprofloxacin (CPFX) Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecali

Fig. 1 Chemical structure of KW-1070

Table1MIC of BAY o 9867 against standard strains

Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega

Fig. 1 Chemical structure of norfioxacin (AM-715)

1272 CHEMOTHERAPY MAR. 1975

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates


CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus


Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone


CHEMOTHERAPY


coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F

semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG

988 CHEMOTHERAPY NOV. 1971

CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin

VOL.42 S-1

Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad

Title 外傷性脊髄損傷患者の泌尿器科学的研究第 3 報 : 上部尿路のレ線学的研究並びに腎機能について Author(s) 伊藤, 順勉 Citation 泌尿器科紀要 (1965), 11(4): Issue Date URL

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

CHEMOTHERAPY

CHEMOTHERAPY FEB Table 1 Background of volunteers

Table 1 Classification of female patients with vesical irritating symptom by their signs : Urinary pain with or without other vesical irritability. s




VOL.30 S-1 CHEMOTHERAPY Table 1 Antibacterial activity of CTT against standard strains Table 2 Antibacterial activity of CTT against standard strains


Title 泌尿器科領域に於ける17-Ketosteroidの研究 17-Ketosteroidの臨床的研究 第 III 篇 : 尿 Author(s) 卜部, 敏入 Citation 泌尿器科紀要 (1958), 4(1): 3-31 Issue Date URL

<95DB8C9288E397C389C88A E696E6462>

VOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant St







A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation

Title 神経因性膀胱にともなう排尿障害に対する塩酸ブナゾシンの臨床効果 - 二重盲検比較試験による検討 - 小柳, 知彦 ; 富樫, 正樹 ; 丸, 彰夫 ; 折笠, 精一 ; 相馬, Author(s) 崎, 淳 ; 安田, 耕作 ; 阿曽, 佳郎 ; 本問, 之夫 ; 三宅, 弘厚生 ; 熊


Physical and Psychological Effects of Stressors in Female College Students Reizou Mita*1, Konosuke Tomabechi*1, Isao Yamaguchi*1, Naoko Soeno*1, Shuhe



VOL.27 S-5 CHEMOTHERAPY Table 1 Clinical evaluations of cefamandole on UTI (1) Benign prostatic hypertrophy (2) Transurethral resection of bladder tum


VOL.27 CHEMOT S-1 HERAPY 185 に感 性 を示 して い たが,臨 床 的 に は無 効 で あ った 本 症 る 細 菌学 的 に も検 討 した が,起 炎菌 と考 え られ る細 菌 を 例 で は 基礎 疾 患 と して縦 隔 洞腫 瘍 が あ り,既 に 副 腎

Postoperative Assessment by Using a Torque Machine (BIODEX) and MRIs in Patients treated for a Recurrent Anterior Dislocation or Subluxation of the Sh


Visual Evaluation of Polka-dot Patterns Yoojin LEE and Nobuko NARUSE * Granduate School of Bunka Women's University, and * Faculty of Fashion Science,

名称未設定-1

Some Investigations of Urinary Candidiasis Chujiro YAMAMOTO, M. D., Mitsushi MIZUTANI, M. D. and Tokuro SATO, M. D. From the Department of Urology, Ni

_念3）医療2009_夏.indd


VOL. 23 NO. 3 CHEMOTHERAPY 1379 Table 1 Susceptibility of clinical isolated strains to Tobramycin

VOL. 21 NO. 2 CHEMOTHERAPY 395

Key words: Antibodies to Leptospira, Tokyo, Uveitis

untitled

VOL.39 S-3

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo





CHEMOTHERAPY OCT Fig. 1 Chemical structure of CVA-K

Staphylococcus sp. K.pneumoniae P.mirabilis C.freundii E. cloacae Serratia sp. P. aeruginosa ml, Enterococcus avium >100ƒÊg/ml

VOL. 43 NO. 4

Table 1 Muscle weight (g) and those ratio (%) in M. quadriceps femoris Table 2 Cross-sectional area (mm2) and those ratio (%) in M, quadriceps femoris

Validation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake Keiko Takahashi *', Yukio Yoshimura *', Ta

Fig.1 Chemical structure of BAY o 9867

CHEMOTHERAPY JUNE 1986

) 5 Lawton QOL 4 4 QOL Lawton 4) Philadelphia Geriatric Center Affect Rating ScaleARS ARS QOL 5) HDS R

ec6


VOL. 28 NO. 2 CHEMOTHERAPY Fig. 1 Chemical structure Cefamandole Cefazolin sodium sodium

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

日本化学療法学会雑誌第59巻第5号

Transcription:

VOL. 23 NO. 1 CHEMOTHERAPY 399 Fig. 1 Stracture of cephradine Chemical name : 7-CD(-)-2-amino-2-(1,4-cyclohexadien-1-y1) -acetamido) -3-methyl-8-oxo-5-thia-1-aza- -bicyclo [4. 2. 0] oct-2-ene-2-carboxylic acid Molecular formula : C16H19N3O4S Molecular weight : 349. 4

400 CHEMOTHERAPY JAN. 1975 Table 1 Cases of drop outs

VOL. 23 NO. 1 CHEMOTHERAPY 401

402 CHEMOTHERAPY JAN. 1975

VOL. 23 NO. 1 CHEMOTHERAPY 403

404 CHEMOTHERAPY JAN: 1975 Table 3 Correlation between clinical results and dosage Table 4 Correlation between clinical results and basic diseases

VOL. 23 NO. 1 CHEMOTHERAPY 405 Table 5 Movements of urinary pathogens

406 CHEMOTHERAPY JAN. 1975 Table 6 Movements of laboratory findings

VOL. 23 NO. 1 CHEMOTHERAPY 407 Table 7 Correlation between cephradine sensitivity and clinical results 5) NEiss E. S. ; et al.: Cephradine : A summary of preclinical and clinical studies and clinical pharmacology. J. Irish Med. Ass. 66: (Suppl.) 1973 CLINICAL EXPERIENCE WITH CEPHRADINE IN URINARY TRACT INFECTIONS JYOICHI KUMAZAWA, SEIICHI NAKAMUTA and SHUNRO MOMOSE Department of Urology, Faculty of Medicine, Kyushu University (Director : Prof. SHUNRO MOMOSE) ASAMI ARIYOSHI, KAZUHIRO OSHIMA, YASUHITO FUJISAWA and YOSHIHARU HIRATSUKA Department of Urology, Faculty of Medicine, Fukuoka University Kozo HIRATA, ICHIKIRO MORITA and SADAMU HIEDA Department of Urology, Fukuoka National Central Hospital YASUHIRO OOTA, YUKIO OSADA and TETSURO TAKESUE Department of Urology, Fukuoka Red Cross Hospital CHUJI TAKAMATSU Department of Urology, Kyushu Cancer Center Hospital SEIICHIRO ANDO and HARUKA HIRANO Department of Urology, Kyushu Kosei Nenkin Hospital HIROYUKI NAGAYOSHI Department of Urology, Shin Nihon Seitetsu Yawata Hospital HIROSHI KIDA and HIROHIKO KIYOHARA Department of Urology, Kitakyushu City Kokura Hospital KOICHI OMARU, MASAAKI HIDAKA and KIMIYA FUJII Department of Urology, Miyazaki Prefectural Hospital HIROSHI NAKAYAMA and MOTONORI KANO Department of Urology, Beppu Nacional Hospital HIROSHI HIRATA and TAKUYA AMANO Department of Urology, Hiroshima Red Cross Hospital SANSHIN HARA, TAKAHIKO HARA, KAZUSHIGE NANRI and AKITO YAMAGUCHI Department of Urology, Iryohojin Sanshin-kai Hara Hospital

408 CHEMOTHERAPY JAN. 1975 1) Cephradine was administered in 115 cases of various urinary tract infections diagnozed byurological Departments of Kyushu Unversity and other allied hospitals. As 12 cases dropped out, examinations were possible in 18 cases of male and 85 cases of female, totalling 103 cases. 2) Among the group administered 1 g daily, the results obtained were excellent in 46 cases, good in 11 cases and poor in 2 cases out of 59 cases, effective ratio being 96. 6%. Among the group administered 2 g daily, the results were excellent in 33 cases, good in 8 cases and poor in 3 cases ratio being 93. 1%. out of 44 cases, effective 3) Among 81 cases of simple urinary tract infection, effective ratio of 100% was obtained in both 1 g group (51 cases) and 2 g group (30 cases). Among 22 cases of complicated urinary tract infection, no difference was noticed between 1 g group (8 cases) and 2 g group (14 cases), effective ratio being 75. 0% and 78. 5% respectively. 4) The largest number of cases was acute simple cystitis, being divided into 1 g group (49 cases) and 2 g group (23 cases). The administration was continued for 3-7 days (4. 9 days on an average), and effective ratio of 100% was obtained in both groups. 5) Gastric malaise was observed in 1 case of 1 g group and in 5 cases of 2 g group, including dropped out case. Leukopenia by receiving an adrenal cortical hormone. was recognized in 1 child of 1 g group, and the patient was released from this side effect 6) Cephradine was proved to be excellent for urinary tract infection, especially that of acute and simple. In these cases, the dosage of 1 g daily for less than 5 days seems to be sufficient in consideration of side effect with the drug.

2024 © docsplayer.net プライバシー | 利用規約 | フィードバック